Recombinant DNA (rDNA) Technology - Global Market Outlook (2017-2023)
According to Stratistics MRC, the Global Recombinant DNA (rDNA) Technology Market is accounted for $499.8 million in 2016 and expected to grow at a CAGR of 6.9% to reach $799.9 million by 2023. Factors influencing the market growth are rise in Genetically Modified (GM) crop, development of biofuel and biopesticides, presence of biopharmaceuticals pipeline and production of various therapeutic proteins. Lack of government funding for research and development in emerging economies, risks involved in usage of genetically modified food and regulatory & ethical challenges associated with gene therapy are hampering the market growth.
Based on component, the Expression systems are used for the production of protein from recombinant DNA molecules. Majorly used expression systems are mammalian, bacterial, insects, and yeast. Development of cell lines such as HEK293 and Chinese Hamster Ovarian (CHO) has contributed to the significant share of mammalian expression system. Further, , ongoing research to explore the prospective of plant as expression system are expected to underpin the adoption of plans expression system for Genetically Modified product development in the future. Furthermore, more than 3000 scientific studies have been carried out to assess the GM products safety in context to its impact on human health and environment.
Based on application, Agricultural plants are one of the most frequently cited cases of genetically modified organisms. Some benefits of genetic engineering in agriculture are increased crop yields, reduces cost for food or drug production, limited need for pesticides, enhanced nutrient composition and food quality, resistance to pests and disease, with enormous food security, and medical benefits. The advantage of recombinant DNA technology is that new combinations of genes are determined in the forefront. GE has also been used against crop pathogens. One of the first and most successful genetically modified crops was a papaya with resistance to ringspot virus. Another example includes the development of bananas resistant to wilt in Uganda.
North America accounted for the maximum share of the market which attributes to a affluent number of biopharmaceutical manufacturing companies are situated in the U.S. In July 2017, U.S witnessed the 1st FDA approval for gene therapy treatment. The treatment was developed for leukemia disorder, in conjugation between the University of Pennsylvania and Novartis Corp. This, in turn, furtherance the enact of rDNA techniques in the region. Asia Pacific is expected to be the fastest growing market. Clinical trials in Asian countries such as India and China are less expensive compared to other regions which made migration of several biopharmaceutical developers towards this region.
Some of the key players in Global Recombinant DNA (rDNA) Technology market are F. Hoffmann-La Roche Ltd, Monsanto Company, Amgen Inc, Biocon, Biogen, Eli Lilly and Company, GenScript, GlaxoSmithKline plc, Horizon Discovery Group PLC, Merck & Co, New England Biolabs., Novartis AG, Novo Nordisk A/S, Pfizer Inc and Profacgen.
Components Covered:
Based on component, the Expression systems are used for the production of protein from recombinant DNA molecules. Majorly used expression systems are mammalian, bacterial, insects, and yeast. Development of cell lines such as HEK293 and Chinese Hamster Ovarian (CHO) has contributed to the significant share of mammalian expression system. Further, , ongoing research to explore the prospective of plant as expression system are expected to underpin the adoption of plans expression system for Genetically Modified product development in the future. Furthermore, more than 3000 scientific studies have been carried out to assess the GM products safety in context to its impact on human health and environment.
Based on application, Agricultural plants are one of the most frequently cited cases of genetically modified organisms. Some benefits of genetic engineering in agriculture are increased crop yields, reduces cost for food or drug production, limited need for pesticides, enhanced nutrient composition and food quality, resistance to pests and disease, with enormous food security, and medical benefits. The advantage of recombinant DNA technology is that new combinations of genes are determined in the forefront. GE has also been used against crop pathogens. One of the first and most successful genetically modified crops was a papaya with resistance to ringspot virus. Another example includes the development of bananas resistant to wilt in Uganda.
North America accounted for the maximum share of the market which attributes to a affluent number of biopharmaceutical manufacturing companies are situated in the U.S. In July 2017, U.S witnessed the 1st FDA approval for gene therapy treatment. The treatment was developed for leukemia disorder, in conjugation between the University of Pennsylvania and Novartis Corp. This, in turn, furtherance the enact of rDNA techniques in the region. Asia Pacific is expected to be the fastest growing market. Clinical trials in Asian countries such as India and China are less expensive compared to other regions which made migration of several biopharmaceutical developers towards this region.
Some of the key players in Global Recombinant DNA (rDNA) Technology market are F. Hoffmann-La Roche Ltd, Monsanto Company, Amgen Inc, Biocon, Biogen, Eli Lilly and Company, GenScript, GlaxoSmithKline plc, Horizon Discovery Group PLC, Merck & Co, New England Biolabs., Novartis AG, Novo Nordisk A/S, Pfizer Inc and Profacgen.
Components Covered:
- Cloning Vector
- Phage
- Bacterial Artificial Chromosome (BAC)
- Human Artificial Chromosome (HAC)
- Yeast Artificial Chromosome (YAC)
- Cosmid
- Plasmid
- Expression System
- Baculovirus/Insect
- Bacteria
- Mammalian
- Yeast
- Other Expression System
- Non-medical
- Specialty Chemicals
- Biotech Crops
- Other Non-Medical Technology
- Medical
- Human Protein
- Therapeutic Agent
- Vaccine
- Health & Disease
- Human
- Animal
- Food & Agriculture
- Environment
- Other Applications
- Academic & Research Institutes
- Pharmaceutical & Biotech Entities
- Other End Users
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL RECOMBINANT DNA (RDNA) TECHNOLOGY MARKET, BY COMPONENT
5.1 Introduction
5.2 Cloning Vector
5.2.1 Phage
5.2.2 Bacterial Artificial Chromosome (BAC)
5.2.3 Human Artificial Chromosome (HAC)
5.2.4 Yeast Artificial Chromosome (YAC)
5.2.5 Cosmid
5.2.6 Plasmid
5.3 Expression System
5.3.1 Baculovirus/Insect
5.3.2 Bacteria
5.3.3 Mammalian
5.3.4 Yeast
5.3.5 Other Expression System
6 GLOBAL RECOMBINANT DNA (RDNA) TECHNOLOGY MARKET, BY PRODUCT
6.1 Introduction
6.2 Non-medical
6.2.1 Specialty Chemicals
6.2.2 Biotech Crops
6.2.3 Other Non-Medical Technology
6.3 Medical
6.3.1 Human Protein
6.3.2 Therapeutic Agent
6.3.3 Vaccine
7 GLOBAL RECOMBINANT DNA (RDNA) TECHNOLOGY MARKET, BY APPLICATION
7.1 Introduction
7.2 Health & Disease
7.2.1 Human
7.2.2 Animal
7.3 Food & Agriculture
7.4 Environment
7.5 Other Applications
8 GLOBAL RECOMBINANT DNA (RDNA) TECHNOLOGY MARKET, BY END USER
8.1 Introduction
8.2 Academic & Research Institutes
8.3 Pharmaceutical & Biotech Entities
8.4 Other End Users
9 GLOBAL RECOMBINANT DNA (RDNA) TECHNOLOGY MARKET, BY GEOGRAPHY
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 U.K
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 F. Hoffmann-La Roche Ltd
11.2 Monsanto Company
11.3 Amgen Inc
11.4 Biocon
11.5 Biogen
11.6 Eli Lilly and Company
11.7 GenScript
11.8 GlaxoSmithKline plc
11.9 Horizon Discovery Group PLC
11.10 Merck & Co
11.11 New England Biolabs.
11.12 Novartis AG
11.13 Novo Nordisk A/S
11.14 Pfizer Inc
11.15 Profacgen
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL RECOMBINANT DNA (RDNA) TECHNOLOGY MARKET, BY COMPONENT
5.1 Introduction
5.2 Cloning Vector
5.2.1 Phage
5.2.2 Bacterial Artificial Chromosome (BAC)
5.2.3 Human Artificial Chromosome (HAC)
5.2.4 Yeast Artificial Chromosome (YAC)
5.2.5 Cosmid
5.2.6 Plasmid
5.3 Expression System
5.3.1 Baculovirus/Insect
5.3.2 Bacteria
5.3.3 Mammalian
5.3.4 Yeast
5.3.5 Other Expression System
6 GLOBAL RECOMBINANT DNA (RDNA) TECHNOLOGY MARKET, BY PRODUCT
6.1 Introduction
6.2 Non-medical
6.2.1 Specialty Chemicals
6.2.2 Biotech Crops
6.2.3 Other Non-Medical Technology
6.3 Medical
6.3.1 Human Protein
6.3.2 Therapeutic Agent
6.3.3 Vaccine
7 GLOBAL RECOMBINANT DNA (RDNA) TECHNOLOGY MARKET, BY APPLICATION
7.1 Introduction
7.2 Health & Disease
7.2.1 Human
7.2.2 Animal
7.3 Food & Agriculture
7.4 Environment
7.5 Other Applications
8 GLOBAL RECOMBINANT DNA (RDNA) TECHNOLOGY MARKET, BY END USER
8.1 Introduction
8.2 Academic & Research Institutes
8.3 Pharmaceutical & Biotech Entities
8.4 Other End Users
9 GLOBAL RECOMBINANT DNA (RDNA) TECHNOLOGY MARKET, BY GEOGRAPHY
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 U.K
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 F. Hoffmann-La Roche Ltd
11.2 Monsanto Company
11.3 Amgen Inc
11.4 Biocon
11.5 Biogen
11.6 Eli Lilly and Company
11.7 GenScript
11.8 GlaxoSmithKline plc
11.9 Horizon Discovery Group PLC
11.10 Merck & Co
11.11 New England Biolabs.
11.12 Novartis AG
11.13 Novo Nordisk A/S
11.14 Pfizer Inc
11.15 Profacgen
LIST OF TABLES
Table 1 Global Recombinant DNA (rDNA) Technology Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)
Table 3 Global Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)
Table 4 Global Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
Table 5 Global Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
Table 6 Global Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
Table 7 Global Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)
Table 8 Global Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)
Table 9 Global Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)
Table 10 Global Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)
Table 11 Global Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)
Table 12 Global Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)
Table 13 Global Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)
Table 14 Global Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
Table 15 Global Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)
Table 16 Global Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)
Table 17 Global Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN)
Table 18 Global Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)
Table 19 Global Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
Table 20 Global Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)
Table 21 Global Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)
Table 22 Global Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)
Table 23 Global Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)
Table 24 Global Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)
Table 25 Global Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)
Table 26 Global Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)
Table 27 Global Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)
Table 28 Global Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)
Table 29 Global Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)
Table 30 Global Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)
Table 31 Global Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)
Table 32 Global Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 33 Global Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
Table 34 Global Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)
Table 35 North America Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)
Table 36 North America Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)
Table 37 North America Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)
Table 38 North America Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
Table 39 North America Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
Table 40 North America Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
Table 41 North America Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)
Table 42 North America Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)
Table 43 North America Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)
Table 44 North America Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)
Table 45 North America Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)
Table 46 North America Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)
Table 47 North America Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)
Table 48 North America Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
Table 49 North America Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)
Table 50 North America Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)
Table 51 North America Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN)
Table 52 North America Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)
Table 53 North America Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
Table 54 North America Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)
Table 55 North America Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)
Table 56 North America Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)
Table 57 North America Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)
Table 58 North America Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)
Table 59 North America Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)
Table 60 North America Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)
Table 61 North America Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)
Table 62 North America Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)
Table 63 North America Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)
Table 64 North America Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)
Table 65 North America Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)
Table 66 North America Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 67 North America Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
Table 68 North America Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)
Table 69 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)
Table 70 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)
Table 71 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)
Table 72 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
Table 73 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
Table 74 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
Table 75 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)
Table 76 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)
Table 77 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)
Table 78 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)
Table 79 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)
Table 80 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)
Table 81 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)
Table 82 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
Table 83 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)
Table 84 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)
Table 85 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN)
Table 86 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)
Table 87 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
Table 88 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)
Table 89 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)
Table 90 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)
Table 91 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)
Table 92 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)
Table 93 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)
Table 94 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)
Table 95 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)
Table 96 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)
Table 97 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)
Table 98 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)
Table 99 Europe Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)
Table 100 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 101 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
Table 102 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)
Table 103 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)
Table 104 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)
Table 105 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)
Table 106 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
Table 107 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
Table 108 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
Table 109 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)
Table 110 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)
Table 111 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)
Table 112 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)
Table 113 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)
Table 114 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)
Table 115 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)
Table 116 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
Table 117 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)
Table 118 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)
Table 119 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN)
Table 120 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)
Table 121 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
Table 122 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)
Table 123 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)
Table 124 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)
Table 125 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)
Table 126 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)
Table 127 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)
Table 128 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)
Table 129 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)
Table 130 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)
Table 131 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)
Table 132 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)
Table 133 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)
Table 134 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 135 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
Table 136 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)
Table 137 South America Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)
Table 138 South America Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)
Table 139 South America Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)
Table 140 South America Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
Table 141 South America Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
Table 142 South America Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
Table 143 South America Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)
Table 144 South America Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)
Table 145 South America Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)
Table 146 South America Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)
Table 147 South America Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)
Table 148 South America Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)
Table 149 South America Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)
Table 150 South America Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
Table 151 South America Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)
Table 152 South America Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)
Table 153 South America Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN)
Table 154 South America Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)
Table 155 South America Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
Table 156 South America Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)
Table 157 South America Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)
Table 158 South America Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)
Table 159 South America Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)
Table 160 South America Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)
Table 161 South America Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)
Table 162 South America Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)
Table 163 South America Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)
Table 164 South America Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)
Table 165 South America Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)
Table 166 South America Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)
Table 167 South America Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)
Table 168 South America Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 169 South America Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
Table 170 South America Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)
Table 171 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)
Table 172 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)
Table 173 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)
Table 174 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
Table 175 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
Table 176 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
Table 177 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)
Table 178 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)
Table 179 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)
Table 180 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)
Table 181 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)
Table 182 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)
Table 183 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)
Table 184 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
Table 185 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)
Table 186 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)
Table 187 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN)
Table 188 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)
Table 189 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
Table 190 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)
Table 191 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)
Table 192 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)
Table 193 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)
Table 194 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)
Table 195 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)
Table 196 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)
Table 197 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)
Table 198 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)
Table 199 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)
Table 200 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)
Table 201 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)
Table 202 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 203 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
Table 204 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)
Table 1 Global Recombinant DNA (rDNA) Technology Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)
Table 3 Global Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)
Table 4 Global Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
Table 5 Global Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
Table 6 Global Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
Table 7 Global Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)
Table 8 Global Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)
Table 9 Global Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)
Table 10 Global Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)
Table 11 Global Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)
Table 12 Global Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)
Table 13 Global Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)
Table 14 Global Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
Table 15 Global Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)
Table 16 Global Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)
Table 17 Global Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN)
Table 18 Global Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)
Table 19 Global Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
Table 20 Global Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)
Table 21 Global Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)
Table 22 Global Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)
Table 23 Global Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)
Table 24 Global Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)
Table 25 Global Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)
Table 26 Global Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)
Table 27 Global Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)
Table 28 Global Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)
Table 29 Global Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)
Table 30 Global Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)
Table 31 Global Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)
Table 32 Global Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 33 Global Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
Table 34 Global Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)
Table 35 North America Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)
Table 36 North America Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)
Table 37 North America Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)
Table 38 North America Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
Table 39 North America Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
Table 40 North America Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
Table 41 North America Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)
Table 42 North America Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)
Table 43 North America Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)
Table 44 North America Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)
Table 45 North America Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)
Table 46 North America Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)
Table 47 North America Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)
Table 48 North America Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
Table 49 North America Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)
Table 50 North America Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)
Table 51 North America Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN)
Table 52 North America Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)
Table 53 North America Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
Table 54 North America Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)
Table 55 North America Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)
Table 56 North America Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)
Table 57 North America Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)
Table 58 North America Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)
Table 59 North America Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)
Table 60 North America Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)
Table 61 North America Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)
Table 62 North America Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)
Table 63 North America Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)
Table 64 North America Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)
Table 65 North America Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)
Table 66 North America Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 67 North America Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
Table 68 North America Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)
Table 69 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)
Table 70 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)
Table 71 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)
Table 72 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
Table 73 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
Table 74 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
Table 75 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)
Table 76 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)
Table 77 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)
Table 78 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)
Table 79 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)
Table 80 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)
Table 81 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)
Table 82 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
Table 83 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)
Table 84 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)
Table 85 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN)
Table 86 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)
Table 87 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
Table 88 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)
Table 89 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)
Table 90 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)
Table 91 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)
Table 92 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)
Table 93 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)
Table 94 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)
Table 95 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)
Table 96 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)
Table 97 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)
Table 98 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)
Table 99 Europe Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)
Table 100 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 101 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
Table 102 Europe Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)
Table 103 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)
Table 104 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)
Table 105 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)
Table 106 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
Table 107 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
Table 108 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
Table 109 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)
Table 110 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)
Table 111 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)
Table 112 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)
Table 113 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)
Table 114 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)
Table 115 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)
Table 116 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
Table 117 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)
Table 118 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)
Table 119 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN)
Table 120 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)
Table 121 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
Table 122 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)
Table 123 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)
Table 124 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)
Table 125 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)
Table 126 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)
Table 127 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)
Table 128 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)
Table 129 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)
Table 130 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)
Table 131 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)
Table 132 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)
Table 133 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)
Table 134 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 135 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
Table 136 Asia Pacific Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)
Table 137 South America Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)
Table 138 South America Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)
Table 139 South America Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)
Table 140 South America Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
Table 141 South America Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
Table 142 South America Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
Table 143 South America Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)
Table 144 South America Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)
Table 145 South America Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)
Table 146 South America Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)
Table 147 South America Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)
Table 148 South America Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)
Table 149 South America Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)
Table 150 South America Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
Table 151 South America Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)
Table 152 South America Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)
Table 153 South America Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN)
Table 154 South America Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)
Table 155 South America Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
Table 156 South America Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)
Table 157 South America Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)
Table 158 South America Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)
Table 159 South America Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)
Table 160 South America Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)
Table 161 South America Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)
Table 162 South America Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)
Table 163 South America Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)
Table 164 South America Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)
Table 165 South America Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)
Table 166 South America Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)
Table 167 South America Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)
Table 168 South America Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 169 South America Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
Table 170 South America Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)
Table 171 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Country (2014-2023) ($MN)
Table 172 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Component (2014-2023) ($MN)
Table 173 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Cloning Vector (2014-2023) ($MN)
Table 174 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC)(2014-2023) ($MN)
Table 175 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC)(2014-2023) ($MN)
Table 176 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC)(2014-2023) ($MN)
Table 177 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Cosmid (2014-2023) ($MN)
Table 178 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Plasmid (2014-2023) ($MN)
Table 179 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Expression System (2014-2023) ($MN)
Table 180 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Baculovirus/insect (2014-2023) ($MN)
Table 181 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Bacteria (2014-2023) ($MN)
Table 182 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Mammalian (2014-2023) ($MN)
Table 183 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Yeast (2014-2023) ($MN)
Table 184 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Other Expression system (2014-2023) ($MN)
Table 185 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Product (2014-2023) ($MN)
Table 186 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Non-medical (2014-2023) ($MN)
Table 187 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Specialty Chemicals (2014-2023) ($MN)
Table 188 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Biotech Crops (2014-2023) ($MN)
Table 189 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Other Non-Medical Technology (2014-2023) ($MN)
Table 190 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Medical (2014-2023) ($MN)
Table 191 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Human Protein (2014-2023) ($MN)
Table 192 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Therapeutic Agent (2014-2023) ($MN)
Table 193 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Vaccine (2014-2023) ($MN)
Table 194 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Application (2014-2023) ($MN)
Table 195 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Health & Disease (2014-2023) ($MN)
Table 196 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Human (2014-2023) ($MN)
Table 197 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Animal (2014-2023) ($MN)
Table 198 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Food & Agriculture (2014-2023) ($MN)
Table 199 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Environment (2014-2023) ($MN)
Table 200 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Other Applications (2014-2023) ($MN)
Table 201 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By End User (2014-2023) ($MN)
Table 202 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 203 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Pharmaceutical & Biotech Entities (2014-2023) ($MN)
Table 204 Middle East & Africa Recombinant DNA (rDNA) Technology Market Outlook, By Other End Users (2014-2023) ($MN)
